Vimeo
LinkedIn
Instagram
Share |

Venture Capital

May 5, 2022

A global surge in start-up funding has prompted some commentators to draw comparisons with the dotcom boom and bust at the turn of this century. A cursory glance at the numbers does hint at some parallels says private markets investment platform Titanbay.

A global surge in start-up funding has prompted some commentators to draw comparisons with the dotcom boom and bust at the turn of this century. A cursory glance at the numbers does hint at some parallels says private markets investment platform Titanbay.

April 22, 2022

Joey Mason and Ed Snow, the founders of Duplex Capital Partners, talk about how their firm enables personalised therapeutics through data-driven technology and leading-edge medical techniques. 

Coming from entrepreneurial healthcare and venture capital company growth backgrounds respectively, Joey Mason and Ed Snow know the pitfalls and opportunities that come from investing in healthcare.

Their firm Duplex Capital Partners aims to profit from investing in “Digitally-based life science technology companies innovating to underpin the next generation of biotechnology products.” Here, they explain what they do and where they think the industry is going.

April 19, 2022

The Covid-19 pandemic has transformed the global economy, accelerating digital transformation trends and disrupting traditional industries. According to private markets investment platform Titanbay, these trends have helped provide an even more fertile backdrop for an already booming global entrepreneurial industry, with tech startups reshaping many aspects of our lives.

The Covid-19 pandemic has transformed the global economy, accelerating digital transformation trends and disrupting traditional industries. According to private markets investment platform Titanbay, these trends have helped provide an even more fertile backdrop for an already booming global entrepreneurial industry, with tech startups reshaping many aspects of our lives.

April 4, 2022

INSPIRA is developing a cost-effective respiratory support system which will function as an artificial lung for deteriorating respiratory patients. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and co-founder Joe Hayon explains the benefits and potential future applications of the system.

INSPIRA is an innovative medical device company which is developing the ART system, a cost-effective early extracorporeal respiratory support system which will function as an artificial lung for deteriorating respiratory patients.

The ART system utilises a new approach based on hemo-protective technology aimed at rebalancing oxygen saturation levels while patients are awake and breathing, potentially minimising the patient's need for invasive mechanical ventilation intervention.

March 24, 2022

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

March 21, 2022

Implementing a successful private markets program as part of a total portfolio is not without some implementation challenges, says Russell Investments’ alternative investments client portfolio manager Darren Spencer, and perhaps the most pressing issue investors face which needs to be solved for is managing the J-curve.

March 10, 2022

Companies developing robotic assistance for spine surgery, innovative treatment of cataracts, 3D cardiac modelling software, extracorporeal respiratory support systems and therapy for glaucoma surgery scar prophylaxis will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Forum on June 6 and 7.

Companies developing robotic assistance for spine surgery, innovative treatment of cataracts, 3D cardiac modelling software, extracorporeal respiratory support systems and therapy for glaucoma surgery scar prophylaxis will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Forum on June 6 and 7.

February 24, 2022

Russell Investments’ alternative investments client portfolio manager Darren Spencer discusses why venture capital should be a focus for all serious investors.

February 7, 2022

Multigenerational wealth-holders and family offices from around the world will gather in-person in London on February 23-24, 2022, for the 18th Family Alternative Investment Forum.

Multigenerational wealth-holders and family offices from around the world will gather in-person in London on February 23-24, 2022, for the 18th Family Alternative Investment Forum.

Click here >>
Close